Clinical Research Directory

Inclusion Criteria: 1. Females under 40 years of age with amenorrhea or oligomenorrhea for at least four months, and elevated follicle-stimulating hormone (FSH) levels \> 25 IU/l on two separate occasions (with a 4-week interval); 2. Ultrasound (B-mode) indicating no antral follicle development in both ovaries for at least 3 months prior to study participation; 3. Those who agree to participate in this study and voluntarily sign the informed consent form. Exclusion Criteria: 1. Individuals over 40 years of age, or under 40 years of age with regular menstruation, normal ovulation, amenorrhea or oligomenorrhea for less than 4 months, and elevated follicle-stimulating hormone (FSH) levels \< 25 IU/l on two or more separate occasions (with a 4-week interval); 2. Those with contraindications to the use of injectable human chorionic gonadotropin (HCG); 3. Those with asthma, epilepsy, heart disease, migraines, renal impairment, hypertension, or other diseases; 4. Patients deemed by the researcher as otherwise unsuitable for participation in this study."